UK becomes first to authorize Merck and Ridgeback Biotherapeutics’ antiviral molnupiravir to treat mild-to-moderate Covid-19
By Jamie Gumbrecht, CNN The UK Medicines and Healthcare Products Regulatory Agency said Thursday it had authorized Merck and Ridgeback…
Continue Reading